Lazard Asset Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.4M | Buy |
|
|||||
|
2025
Q2 | $7.05M | Buy |
|
|||||
|
2025
Q1 | $1.25M | Buy |
|
|||||
|
2024
Q4 | $598K | Sell |
|
|||||
|
2024
Q3 | $695K | Sell |
|
|||||
|
2024
Q2 | $783K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $834K | Sell |
|
|||||
|
2023
Q3 | $806K | Hold |
|
|||||
|
2023
Q2 | $913K | Buy |
|
|||||
|
2023
Q1 | $1.07M | Sell |
|
|||||
|
2022
Q4 | $1.28M | Buy |
|
|||||
|
2022
Q3 | $1.3M | Hold |
|
|||||
|
2022
Q2 | $1.36M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $1.07M | Buy |
|